CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8700 |
| Open | 1.9500 |
| Bid | 1.8500 x 1100 |
| Ask | 1.9000 x 3200 |
| Day's range | 1.8500 - 2.0000 |
| 52-week range | 1.5050 - 7.5300 |
| Volume | |
| Avg. volume | 1,109,848 |
| Market cap | 124.257M |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4090 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.14 |
- Simply Wall St.
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...
- Motley Fool
CytomX Therapeutics (CTMX) Q1 2022 Earnings Call Transcript
With me today are Dr. Sean McCarthy, CytomX's chief executive offices and chairman; Amy Peterson, president and chief operating officer; and Carlos Campoy, chief financial officer. Please note that during today's call, we will be making forward-looking statements.
- Zacks
CytomX Therapeutics (CTMX) Reports Q1 Loss, Lags Revenue Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -5.71% and 21.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
